Bharat Immunologicals & Biologicals Corporation Limited
BSE: BIBCL.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Dhananjay Kumar Tiwary
- Headquarters
- Bulandshahr, India
- IPO year
- 2024
- Market cap
- ₹840.7M
- Website
- http://www.bibcol.com
Loading BIBCL…
Loading profile data…Frequently asked questions about BIBCL
What does Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) do?
Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio Vaccine (OPV), Zinc Tablets, B...
Where does BIBCL.BO trade?
Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) trades on the Bombay Stock Exchange.
What sector is BIBCL.BO in?
Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Bharat Immunologicals & Biologicals Corporation Limited?
Dhananjay Kumar Tiwary is the chief executive officer of Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO).
Where is Bharat Immunologicals & Biologicals Corporation Limited headquartered?
Bharat Immunologicals & Biologicals Corporation Limited is headquartered in India.
Does BIBCL.BO pay a dividend?
Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BIBCL.BO go public?
Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) completed its initial public offering in 2024.